Biosante Pharmaceuticals shares owned by Credit Suisse
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.7M | 32k | 55.14 |
| 2023-09-30 | $1.5M | 26k | 58.06 |
| 2023-06-30 | $1.2M | 23k | 53.83 |
| 2023-03-31 | $693k | 17k | 39.72 |
| 2022-12-31 | $701k | 17k | 40.23 |
| 2022-09-30 | $450k | 14k | 32.09 |
| 2022-06-30 | $411k | 14k | 29.49 |
| 2022-03-31 | $408k | 15k | 27.74 |
| 2021-12-31 | $695k | 15k | 46.66 |
| 2021-09-30 | $928k | 28k | 33.71 |
| 2021-06-30 | $1.1M | 30k | 35.96 |
| 2021-03-31 | $972k | 27k | 36.13 |
| 2020-12-31 | $945k | 31k | 30.39 |
| 2020-09-30 | $782k | 28k | 28.19 |
| 2020-06-30 | $1.4M | 43k | 32.31 |
| 2020-03-31 | $667k | 17k | 40.38 |
| 2019-12-31 | $518k | 8.4k | 61.82 |
| 2019-09-30 | $496k | 6.8k | 72.72 |
| 2019-06-30 | $550k | 6.5k | 83.92 |
| 2019-03-31 | $512k | 7.3k | 70.68 |
| 2018-12-31 | $345k | 7.7k | 45.04 |
| 2018-09-30 | $348k | 6.1k | 57.35 |
| 2018-06-30 | $581k | 8.7k | 67.08 |
| 2018-03-31 | $386k | 6.6k | 58.15 |
| 2017-12-31 | $0 | 7.5k | 0.00 |
| 2017-09-30 | $612k | 12k | 52.53 |
| 2017-06-30 | $0 | 5.7k | 0.00 |
| 2017-03-31 | $0 | 12k | 0.00 |
| 2016-12-31 | $846k | 14k | 60.46 |
| 2016-09-30 | $810k | 12k | 66.46 |
| 2016-06-30 | $1.3M | 23k | 55.82 |
| 2016-03-31 | $783k | 23k | 33.64 |
| 2015-12-31 | $1.5M | 34k | 44.62 |
| 2015-09-30 | $482k | 12k | 40.00 |
| 2015-06-30 | $1.8M | 24k | 76.92 |
| 2015-03-31 | $926k | 15k | 62.56 |
| 2014-12-31 | $886k | 16k | 56.37 |
| 2014-09-30 | $394k | 14k | 27.69 |
| 2014-06-30 | $1.3M | 39k | 34.51 |
| 2014-03-31 | $640k | 21k | 31.28 |